ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference

Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 8:30 a.m. PT in San Francisco, CA.

 

About ReNAgade Therapeutics

 

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.

 

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.

 

ReNAgade Therapeutics—RNA Without Limits

 

For more information about the company, its technologies, and its leadership, visit www.renagadetx.com

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240104374758/en/

en | US61732R2067 | RENAGADE | boerse | 64535199 |